GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Symbol
Price
 
Change
%Change
BMY
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Critics say trucking companies can change their name and re-register with the government to avoid liability and poor safety records. These so-called "chameleon carriers" are also more likely to get into severe accidents, according to the Government Accountability Office. CNBC's Eamon Javers reports.

  • The truck collision that injured Tracy Morgan and the fatal Fedex crash with a bus in California grab the nation's attention but accidents like these happen nearly 11 times a day. CNBC's Eamon Javers investigates the growing problem of truck crashes.

  • CNBC's Collision Course takes a ride in a Volvo truck equipped with enhanced cruise controls and lane departure warning systems to see how technology can make our roads safer. CNBC's Eamon Javers Reports.